In addition to these clinical presentations, Nurix and its collaborators will also present new mechanistic insights into resistance to Bruton’s tyrosine kinase (BTK) targeted therapies at a separate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback